CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
New Potential Targets of Glucagon-Like Peptide 1 Receptor Agonists in Pancreatic β-Cells and Hepatocytes
Won-Young Lee
Endocrinol Metab. 2017;32(1):1-5.   Published online February 6, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.1

Excel Download

New Potential Targets of Glucagon-Like Peptide 1 Receptor Agonists in Pancreatic β-Cells and Hepatocytes
Endocrinology and Metabolism. 2017;32(1):1   Crossref logo
Link1 Link2 Link3

The potential benefits of glucagon-like peptide-1 receptor agonists for diabetic retinopathy
Peptides. 2018;100:123-126   Crossref logo
Link1 Link2

Should we still be concerned about the potential side effects of glucagon-like peptide-1 receptor agonists on thyroid C cells?
Endocrine. 2014;48(1):47-52   Crossref logo
Link1 Link2 Link3

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
Diabetes mellitus. 2020;23(1):56-64   Crossref logo
Link1 Link2 Link3

Glucagon-like peptide-1 receptor agonists
Handbook of Incretin-based Therapies in Type 2 Diabetes. 2016;31-43   Crossref logo
Link1

Risk of acute pancreatitis after glucagon-like peptide-1 receptor agonists
Pancreatology. 2019;19:S45-S46   Crossref logo
Link1 Link2

Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2017;Volume 10:79-87   Crossref logo
Link1 Link2

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2017;Volume 10:123-139   Crossref logo
Link1 Link2

Medicinal Chemistry of Glucagon-Like Peptide Receptor Agonists
Progress in Medicinal Chemistry. 2013;45-96   Crossref logo
Link1 Link2

Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2012;165   Crossref logo
Link1